Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Willixhofer

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
JACC. Advances|September 23, 2024
DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac AmyloidosisRené Rettl, Raffaella Calabretta, Franz Duca, et al.
European Journal of Internal Medicine|July 24, 2024
Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fractionChristina Kronberger, Katharina Mascherbauer, Robin Willixhofer, et al.
International Journal of Cardiology. Heart & Vasculature|October 23, 2025
Left atrial appendage thrombi despite oral anticoagulation in transthyretin amyloid cardiomyopathy patients undergoing electrical cardioversion for atrial fibrillation or - flutterMichael Poledniczek, Christina Kronberger, Bernhard Gregshammer, et al.
Frontiers in Medicine|September 24, 2025
The 6-min walk test in transthyretin cardiac amyloidosis: prognostic utility put to the real-world testMichael Poledniczek, Anna Grubmüller, Christina Kronberger, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2023
Reduction in <sup>99m</sup>Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathyRené Rettl, Raffaella Calabretta, Franz Duca, et al.
ESC Heart Failure|July 3, 2026
Prognostic Impact of Chronotropic Incompetence in Transthyretin Cardiac Amyloidosis. A multicentre studyDamiano Magrì, Nikita Ermolaev, Vincenzo Castiglione, et al.
Heart (British Cardiac Society)|January 11, 2025
Prevalence and functional impact of chronotropic incompetence in amyloid cardiomyopathy: a multicentre analysisDamiano Magrì, Nikita Ermolaev, Robin Willixhofer, et al.
Journal of Clinical Medicine|December 30, 2025
Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging FeaturesCarolina Donà, Renè Rettl, Christina Binder-Rodriguez, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
JACC. Advances|September 23, 2024
DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac AmyloidosisRené Rettl, Raffaella Calabretta, Franz Duca, et al.
European Journal of Internal Medicine|July 24, 2024
Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fractionChristina Kronberger, Katharina Mascherbauer, Robin Willixhofer, et al.
International Journal of Cardiology. Heart & Vasculature|October 23, 2025
Left atrial appendage thrombi despite oral anticoagulation in transthyretin amyloid cardiomyopathy patients undergoing electrical cardioversion for atrial fibrillation or - flutterMichael Poledniczek, Christina Kronberger, Bernhard Gregshammer, et al.
Frontiers in Medicine|September 24, 2025
The 6-min walk test in transthyretin cardiac amyloidosis: prognostic utility put to the real-world testMichael Poledniczek, Anna Grubmüller, Christina Kronberger, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2023
Reduction in <sup>99m</sup>Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathyRené Rettl, Raffaella Calabretta, Franz Duca, et al.
ESC Heart Failure|July 3, 2026
Prognostic Impact of Chronotropic Incompetence in Transthyretin Cardiac Amyloidosis. A multicentre studyDamiano Magrì, Nikita Ermolaev, Vincenzo Castiglione, et al.
Heart (British Cardiac Society)|January 11, 2025
Prevalence and functional impact of chronotropic incompetence in amyloid cardiomyopathy: a multicentre analysisDamiano Magrì, Nikita Ermolaev, Robin Willixhofer, et al.
Journal of Clinical Medicine|December 30, 2025
Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging FeaturesCarolina Donà, Renè Rettl, Christina Binder-Rodriguez, et al.
Heart (British Cardiac Society)|April 16, 2025
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathyRobin Willixhofer, Massimo Mapelli, Nikita Baracchini, et al.
Pageof 4